Skip to content
MarketScale
‹ Back to IndustriesHealthcare

DroneUp and UPS Test Unmanned Systems for Coronavirus Response

LAWRENCEVILLE, Virginia, April 21, 2020 – DroneUp recently partnered with UPS (NYSE:UPS) and subsidiary UPS Flight Forward (UPSFF) with Virginia’s Center for Innovative Technology (CIT), and Workhorse Group in tests designed to determine how unmanned aerial systems can assist medical professionals in their fight to stop the spread of the Coronavirus. As healthcare practitioners nationwide…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
DroneUp and UPS Test Unmanned Systems for Coronavirus Response

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

LAWRENCEVILLE, Virginia, April 21, 2020 DroneUp recently partnered with UPS (NYSE:UPS) and subsidiary UPS Flight Forward (UPSFF) with Virginia’s Center for Innovative Technology (CIT), and Workhorse Group in tests designed to determine how unmanned aerial systems can assist medical professionals in their fight to stop the spread of the Coronavirus.

As healthcare practitioners nationwide and around the world race to contain the virus and save lives, time is of the essence. Experts in the healthcare industry and in government are calling for technology solutions that can speed the pace of testing and treatment for infected patients. They also express concern for healthcare providers on the front lines who interact with potentially infected patients on a daily basis. Technology leaders see autonomous drones as a potentially valuable solution.

“I am encouraged to see so many private sector partners stepping up and thinking innovatively as we work together to combat COVID-19,” said Virginia Governor Ralph Northam. “Drones can be an important way to deliver medical supplies while people stay home to adhere to our social distancing guidelines. Virginia is well-positioned to be a leader in the unmanned system industry, and we are pleased to be part of this initiative.”

The tests in Virginia evaluated the commercial drone industry’s ability to provide and scale small unmanned aerial systems to support various use cases to speed and assist the U.S. healthcare system during the novel Coronavirus crisis.

“We’ve proven through ongoing commercial drone delivery programs that effective drone delivery of medical products is faster than conventional ground-based transportation,” said Scott Price, UPS chief strategy and transformation officer. “Drones offer a low-touch option for delivery of lab specimens and medical products that could make a significant impact in an urgent response application.”

Data collected during this fast-paced simulation will be used to determine how private-sector drone operators can effectively supplement emergency response and certain patient care. The findings and recommendations will be included in a report to the White House, where leaders are considering what role the nascent industry could play in the Coronavirus response.

“Many in the public – along with federal, state and local officials – are asking how drones can be used in this time of crisis,” said Tom Walker, DroneUp CEO. “Rather than speculate, it is incumbent upon our industry to conduct operationally-based exercises that produce factual data and lessons learned to ensure we can respond safely, effectively and efficiently when called upon. Data collected now will impact our capabilities beyond the COVID-19 outbreak we are currently facing.”

The test participants conducted exercises over three days earlier this month on the vacant campus of St. Paul’s College, in Lawrenceville, Virginia. The Brunswick County facility, which closed to the public in 2013, provided a safe, complex community environment to test package deliveries by drones under a variety of conditions. The exercises focused on delivery to residential and commercial areas with the aim of determining the following:

  • Safe operational capacities based on existing technologies, policies, personnel and environmental restrictions
  • Airspace de-confliction and operator safety policies necessary for peak optimal capacity
  • Processes, policies and training necessary to conduct efficient, safe and effective delivery operations during day and night
  • Proposed policy changes that would further enable the use of these autonomous airborne advanced technologies

Virginia’s Center for Innovative Technology (CIT), a nonprofit corporation, has been Virginia’s primary driver of innovation and entrepreneurship since 1985. Virginia’s commitment to unmanned system innovation led to the development of The Virginia Unmanned Systems center at CIT to support this rapidly growing and innovative industry.

“Our thoughts are with those who have been most affected by this crisis, said Ed Albrigo, CIT President and CEO. “CIT is committed to exploring innovative responses to the COVID -19 pandemic including emergency package delivery by drones. We appreciate the willingness of DroneUp, UPS, and Workhorse to be part of the solution.”

“We’re proud to be able to help through the use of our drone technology and aerospace team in this crisis,” said Duane Hughes, Workhorse Group CEO. “We’ve made hundreds of autonomous drone deliveries in the National Airspace System over the last four years using our proprietary technology combined with our all-electric delivery vehicles. We have a comprehensive understanding of the benefits provided by a drone delivery when speed counts. The people of Workhorse are ready to help through these trying times in any way we can.”

Last year, UPS initiated the first ongoing revenue-generating drone delivery service at WakeMed’s flagship hospital and the campus in Raleigh, N.C. UPS also established UPS Flight Forward, which later earned the Federal Aviation Administration’s standard Part 135 Standard certification to operate a drone airline. UPS has worked with innovative drone technology partners and aviation regulators for years to advance the use of drones for delivery.

DroneUp provides end-to-end aerial data collection services for its clients. The company also qualifies and deploys drone pilots to serve a variety of commercial industries. Workhorse makes electrically powered utility and delivery vehicles, including drones. In 2017, UPS and Workhorse successfully tested delivery drones launched from the top of a UPS package delivery van.

###

About DroneUp

Founded by Tom Walker in 2016, DroneUp provides complete drone solution services that include Part 107 pilots, aerial data collection, training, program integration, and equipment sales to commercial industries and public sector organizations. DroneUp operates globally with more than 10,000 certified drone pilots. DroneUp is headquartered in Virginia Beach, Virginia, and a SWaM or Small, Women-owned, and Minority-owned Business certified as a small business by the Commonwealth of Virginia. For more information: droneup.com.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended AstraZeneca and Daiichi Sankyo’s Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly is investing $6.5 billion in a Houston manufacturing facility set to open around 2030, primarily to scale production of Foundayo, its oral GLP-1 treatment. The project signals a broader shift in U.S. pharmaceutical manufacturing reshoring and underscores the supply chain challenge of forecasting demand and building capacity years in advance for breakthrough therapeutics.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain: Lilly's CEO noted that one-third of new GLP-1 pill patients are now choosing Foundayo, illustrating fast-moving market share shifts that complicate production planning years in advance
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

Waiting for perfectly clean data is stalling healthcare AI, not protecting it

Healthcare organizations often delay AI initiatives waiting for perfectly clean data, but this assumption no longer holds: reliable subsets and synthetic data allow projects to start now while data work continues in parallel. Success requires starting with business outcomes rather than technology capabilities, and embedding governance in product strategy before implementation, not after.

  • 01Waiting for 100% clean data is effectively a decision never to start; hospital AI projects can begin on reliable data subsets while quality work continues in parallel.
  • 02Frame AI decisions around business outcomes (revenue growth, cost reduction, competitive advantage, new products, or ecosystem influence) rather than asking what AI can do.
  • 03Governance should be part of product strategy before design or purchase, especially as agentic AI takes actions—such as handling many revenue-cycle denials—while routing the rest to humans.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512